Literature DB >> 22622051

Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peers.

Sheela N Magge1, Divya Prasad, Dorit Koren, Paul R Gallagher, Emile R Mohler, Nicolas Stettler, Lorraine E Levitt Katz, Daniel J Rader.   

Abstract

OBJECTIVE: To compare lipoprotein profiles of prediabetic to normoglycemic obese adolescents. STUDY
DESIGN: Cross-sectional study of 95 obese, pubertal adolescents (12-17 years), who underwent oral glucose tolerance test, lipid panel, and lipoprotein subclass particle analysis (nuclear magnetic resonance spectroscopy). Univariate and linear regression analyses compared prediabetic and normoglycemic groups.
RESULTS: Of 95 obese adolescents enrolled in the study, 22.1% (n = 21) had prediabetes. They were similar to normoglycemic adolescents (n = 74) in age, race, body mass index, standard lipids, total low-density lipoprotein particles (LDL-P), and total high-density lipoprotein particles (HDL-P). However, prediabetics had higher concentrations of small LDL-P (714.0 ± 288.0 vs 537.7 ± 266.5 nmol/L, P = .01) and smaller LDL-P size (20.73 ± 0.41 vs 21.18 ± 0.65 nm, P = .003), than normoglycemic youth. Prediabetics had higher small HDL-P (18.5 ± 3.8 vs 16.6 ± 3.9 umol/L, P = .046), lower large HDL-P (4.49 ± 2.0 vs 6.32 ± 2.6 umol/L, P = .004), and smaller HDL-P size (8.73 ± 0.31 vs 9.01 ± 0.39 nm, P = .003). After adjusting for demographics, Tanner stage, and body mass index using multiple linear regression, all differences remained significant except for small HDL-P. After additional adjustment for Homeostasis Model Assessment-Insulin Resistance Index, only LDL-P size difference remained significant.
CONCLUSION: Obese prediabetic adolescents have a significantly more atherogenic lipoprotein profile compared with obese normoglycemic peers. Prediabetic adolescents may benefit from more aggressive interventions to decrease future cardiovascular risk.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622051      PMCID: PMC3430826          DOI: 10.1016/j.jpeds.2012.04.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  20 in total

1.  Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.

Authors:  Christian Meyer; Walkyria Pimenta; Hans J Woerle; Timon Van Haeften; Ervin Szoke; Asimina Mitrakou; John Gerich
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

2.  Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects.

Authors:  Auni Juutilainen; Seppo Lehto; Tapani Rönnemaa; Kalevi Pyörälä; Markku Laakso
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

3.  The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study.

Authors:  Angela D Liese; Ralph B D'Agostino; Richard F Hamman; Patrick D Kilgo; Jean M Lawrence; Lenna L Liu; Beth Loots; Barbara Linder; Santica Marcovina; Beatriz Rodriguez; Debra Standiford; Desmond E Williams
Journal:  Pediatrics       Date:  2006-10       Impact factor: 7.124

4.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

Authors:  C D Gardner; S P Fortmann; R M Krauss
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

5.  Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.

Authors:  Andreas Festa; Ken Williams; Anthony J G Hanley; James D Otvos; David C Goff; Lynne E Wagenknecht; Steven M Haffner
Journal:  Circulation       Date:  2005-06-28       Impact factor: 29.690

6.  Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.

Authors:  David C Goff; Ralph B D'Agostino; Steven M Haffner; James D Otvos
Journal:  Metabolism       Date:  2005-02       Impact factor: 8.694

7.  Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Authors:  Elizabeth L M Barr; Paul Z Zimmet; Timothy A Welborn; Damien Jolley; Dianna J Magliano; David W Dunstan; Adrian J Cameron; Terry Dwyer; Hugh R Taylor; Andrew M Tonkin; Tien Y Wong; John McNeil; Jonathan E Shaw
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

Review 8.  The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity.

Authors:  J E Gerich
Journal:  Endocr Rev       Date:  1998-08       Impact factor: 19.871

9.  In vivo insulin sensitivity and lipoprotein particle size and concentration in black and white children.

Authors:  Stephen F Burns; SoJung Lee; Silva A Arslanian
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 17.152

10.  Prevalence of pre-diabetes and its association with clustering of cardiometabolic risk factors and hyperinsulinemia among U.S. adolescents: National Health and Nutrition Examination Survey 2005-2006.

Authors:  Chaoyang Li; Earl S Ford; Guixiang Zhao; Ali H Mokdad
Journal:  Diabetes Care       Date:  2008-10-28       Impact factor: 17.152

View more
  9 in total

1.  Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents.

Authors:  Russell Jago; Kimberly L Drews; James D Otvos; Gary D Foster; Marsha D Marcus; John B Buse; Michele Mietus-Snyder; Steven M Willi
Journal:  J Pediatr       Date:  2014-02-05       Impact factor: 4.406

2.  Superiority of lipoprotein particle number to detect associations with arterial thickness and stiffness in obese youth with and without prediabetes.

Authors:  Amy S Shah; W Sean Davidson; Zhiqian Gao; Lawrence M Dolan; Thomas R Kimball; Elaine M Urbina
Journal:  J Clin Lipidol       Date:  2016-02-16       Impact factor: 4.766

3.  Sex Differences in Cardiometabolic Risk Factors among Hispanic/Latino Youth.

Authors:  Carmen R Isasi; Christina M Parrinello; Guadalupe X Ayala; Alan M Delamater; Krista M Perreira; Martha L Daviglus; John P Elder; Ashley N Marchante; Shrikant I Bangdiwala; Linda Van Horn; Mercedes R Carnethon
Journal:  J Pediatr       Date:  2016-06-22       Impact factor: 4.406

4.  Pre-diabetes in overweight youth and early atherogenic risk.

Authors:  Stephen F Burns; SoJung Lee; Fida Bacha; Hala Tfayli; Tamara S Hannon; Silva A Arslanian
Journal:  Metabolism       Date:  2014-08-27       Impact factor: 8.694

5.  Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease.

Authors:  W Sean Davidson; Anna Heink; Hannah Sexmith; Lawrence M Dolan; Scott M Gordon; James D Otvos; John T Melchior; Deborah A Elder; Jane Khoury; Esmond Geh; Amy S Shah
Journal:  J Lipid Res       Date:  2017-07-25       Impact factor: 5.922

Review 6.  Dyslipidemia in Pediatric Type 2 Diabetes Mellitus.

Authors:  Bhuvana Sunil; Ambika P Ashraf
Journal:  Curr Diab Rep       Date:  2020-09-09       Impact factor: 4.810

7.  Nuclear Magnetic Resonance Derived Biomarkers for Evaluating Cardiometabolic Risk in Youth and Young Adults Across the Spectrum of Glucose Tolerance.

Authors:  Stephanie T Chung; Samantha T Matta; Abby G Meyers; Celeste K Cravalho; Alfredo Villalobos-Perez; Joshua M Dawson; Vandhna R Sharma; Maureen L Sampson; James D Otvos; Sheela N Magge
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-18       Impact factor: 5.555

8.  Oxidized low density lipoprotein and total antioxidant capacity in type-2 diabetic and impaired glucose tolerance Saudi men.

Authors:  Essam Eldin Mohamed Nour Eldin; Abdullah Almarzouki; Adel Mohamed Assiri; Osman Mohammed Elsheikh; Badreldin Elsonni Abdalla Mohamed; Abdullatif Taha Babakr
Journal:  Diabetol Metab Syndr       Date:  2014-08-30       Impact factor: 3.320

9.  Postprandial dyslipidemia in insulin resistant states in adolescent populations.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  J Biomed Res       Date:  2020-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.